Charles Carroll Financial Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,455
Closed -$227K 40
2023
Q3
$227K Buy
1,455
+102
+8% +$16.8K 0.28% 38
2023
Q2
$224K Sell
1,353
-400
-23% -$64.6K 0.29% 37
2023
Q1
$272K Sell
1,753
-1,850
-51% -$299K 0.42% 33
2022
Q4
$637K Buy
3,603
+100
+3% +$17.3K 0.98% 25
2022
Q3
$572K Hold
3,503
0.92% 25
2022
Q2
$622K Buy
+3,503
New +$624K 0.81% 27

Other funds holding JNJ

Charles Carroll Financial Partners's JNJ Position: Q4 2023 in Review

Charles Carroll Financial Partners sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 1,455 shares — an estimated $227K sold.

Charles Carroll Financial Partners first reported a position in JNJ in Q2 2022 and held it in 6 quarters. The position peaked at $637K in Q4 2022. 3,869 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Charles Carroll Financial Partners reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
  • Charles Carroll Financial Partners sold 1,455 Johnson & Johnson shares in Q4 2023, an estimated $227K.
  • Charles Carroll Financial Partners first reported a position in Johnson & Johnson in Q2 2022 and held it in 6 quarters.
  • Charles Carroll Financial Partners's Johnson & Johnson position peaked at $637K in Q4 2022.
  • 3,869 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Charles Carroll Financial Partners's 13F filing for Q4 2023, filed 6 Feb 2024.